Publicacións (103) Publicacións de Juan José Gavira Gómez

2024

  1. Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert

    Revista Espanola de Cardiologia

  2. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

    Revista Espanola de Cardiologia

2023

  1. Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene

    Stem Cell Research, Vol. 71

  2. Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure

    Journal of Personalized Medicine, Vol. 13, Núm. 7

  3. Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR

    International Journal of Cardiovascular Imaging, Vol. 39, Núm. 9, pp. 1765-1774

  4. Systemic lupus erythematosus myocarditis after COVID-19 vaccination

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 114-116

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

  2. Fabrication of human myocardium using multidimensional modelling of engineered tissues

    Biofabrication, Vol. 14, Núm. 4

  3. Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896

  4. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 710-717

2021

  1. Clinical Profile and Prognosis of a Real-World Cohort of Patients With Moderate or Severe Cancer Therapy-Induced Cardiac Dysfunction

    Frontiers in Cardiovascular Medicine, Vol. 8

  2. Long-term prognostic value of coronary CTA in orthotopic heart transplant recipients

    American Journal of Roentgenology, Vol. 216, Núm. 5, pp. 1216-1221

  3. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

    Journal of the American College of Cardiology, Vol. 77, Núm. 12, pp. 1503-1516

  4. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

  5. Surgical resection of a transcatheter valve after 8 years of implantation and replacement by aortic bioprosthesis

    Cirugia Cardiovascular, Vol. 28, Núm. 6, pp. 353-356

  6. Valor de la resonancia magnética cardiaca en la coexistencia de TakoTsubo y enfermedad arterial coronaria.: ¿Una coincidencia significativa?

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 4, Núm. 2, pp. 26-28

2020

  1. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering

    Frontiers in Bioengineering and Biotechnology, Vol. 8

  2. Diagnóstico por imagen de la disección arterial coronaria espontánea

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 3, Núm. 2, pp. 14-17

  3. Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?

    Journal of Clinical Medicine, Vol. 9, Núm. 2

  4. Expert consensus on multidisciplinary management and integrated approaches in heart failure. Continuity of care from hospital discharge to primary care

    Revista Espanola de Cardiologia Suplementos, Vol. 20, pp. 3-12